Literature DB >> 26367226

Transmission of CML or of t(9; 22) and BCR/ABL? They are not the same.

R P Gale1, J F Apperley1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26367226     DOI： 10.1038/bmt.2015.199

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  6 in total

1.  Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain.

Authors:  Simona Soverini; Caterina De Benedittis; K Machova Polakova; Adela Brouckova; David Horner; Michele Iacono; Fausto Castagnetti; Gabriele Gugliotta; Francesca Palandri; Cristina Papayannidis; Ilaria Iacobucci; Claudia Venturi; Maria Teresa Bochicchio; Hana Klamova; Federica Cattina; Domenico Russo; Paola Bresciani; Gianni Binotto; Barbara Giannini; Alexander Kohlmann; Torsten Haferlach; Andreas Roller; Gianantonio Rosti; Michele Cavo; Michele Baccarani; Giovanni Martinelli
Journal:  Blood       Date:  2013-06-21       Impact factor: 22.113

2.  Inadvertent transmission of occult CML through allo-SCT.

Authors:  M D de Brito; F Campilho; R Branca; C P Vaz; A Campos
Journal:  Bone Marrow Transplant       Date:  2015-01-12       Impact factor: 5.483

3.  Sex differences in the incidence of chronic myeloid leukemia.

Authors:  Tomas Radivoyevitch; Gradimir M Jankovic; Ramon V Tiu; Yogen Saunthararajah; Robert C Jackson; Lynn R Hlatky; Robert Peter Gale; Rainer K Sachs
Journal:  Radiat Environ Biophys       Date:  2013-12-13       Impact factor: 1.925

4.  Chromosomal characteristics of chronic and blastic phases of Ph-positive chronic myeloid leukemia.

Authors:  N Sadamori; M Matsunaga; E Yao; M Ichimaru; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1985-02-01

5.  The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease.

Authors:  S Bose; M Deininger; J Gora-Tybor; J M Goldman; J V Melo
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

6.  The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001.

Authors:  Wan-Ling Hsu; Dale L Preston; Midori Soda; Hiromi Sugiyama; Sachiyo Funamoto; Kazunori Kodama; Akiro Kimura; Nanao Kamada; Hiroo Dohy; Masao Tomonaga; Masako Iwanaga; Yasushi Miyazaki; Harry M Cullings; Akihiko Suyama; Kotaro Ozasa; Roy E Shore; Kiyohiko Mabuchi
Journal:  Radiat Res       Date:  2013-02-11       Impact factor: 2.841
  6 in total
  2 in total

Review 1.  Why chronic myeloid leukaemia cannot be cured by tyrosine kinase-inhibitors.

Authors:  Michele Baccarani; Robert Peter Gale
Journal:  Leukemia       Date:  2021-05-17       Impact factor: 11.528

2.  Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia.

Authors:  Nicoletta Vitale; Francesca Orso; Mohammad Houshmand; Alessandro Cignetti; Ivan Molineris; Valentina Gaidano; Stefano Sainas; Marta Giorgis; Donatella Boschi; Carmen Fava; Alice Passoni; Marta Gai; Massimo Geuna; Federica Sora; Alessandra Iurlo; Elisabetta Abruzzese; Massimo Breccia; Olga Mulas; Giovanni Caocci; Fausto Castagnetti; Daniela Taverna; Salvatore Oliviero; Fabrizio Pane; Marco Lucio Lolli; Paola Circosta; Giuseppe Saglio
Journal:  Cell Death Dis       Date:  2022-06-30       Impact factor: 9.685
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.